FREE SHIPPING ON ORDERS OVER £60 (UK)

Fernando Sánchez Dragó Visit Hifas da Terra to know research in mycology applied to health

Fernando Sánchez Dragó visita Hifas da Terra para conocer la investigación en micología aplicada a la salud

Marta Hifas |

Hifas da Terra receives the writer Fernando Sánchez Dragó, that travels to Pontevedra to know the scientific activity of the Galician company in mycology applied to health.
Natural connection
After reading the last work of Fernando Sánchez Dragó, Shangri-la, the elixir of eternal youthIn Hifas da Terra we accept the challenge declared in the book. In this, under an epigraph dedicated to the PHARMACOPEA DEL CELESTE EMPIRE - in which we talk about the fungi Reishi and Cordyceps -, the author mentions Hifas da Terra, of which he says he has "good opinion" and whose activity linked to fungi "will try to inform themselves" after finishing the work in question.
SANCHEZ-DRAGO-VISITA-HIFAS-DA-TERRA
Scientific evidence in mycotherapy applied to health Now, six months after the publication of Shangri-la, the elixir of eternal youth, Fernando Sánchez Dragó, knows In situ research projects that from the Biotech Galician we carry out with two of the fungi he includes in his so -called secret formula of youth and that, as he has already assured on other occasions, "makes his 80 years vitality when he was 20." In Hifas da Terra, as scientists and experts in mycology, we will explain our work philosophy and how we obtain extracts from our ecological crops. The extracts, the basis of our mycotherapy formulas, have already evidenced Anticancer activity on colorectal cancer cells in a recent essay carried out by the University of A Coruña. Although the writer's approach to mycotherapy has been established, fundamentally, based on the antioxidant properties of some fungi, from Hifas da Terra we will present other important health activities, among which those related to the cardiovascular system. Thus, through the Dysmetasin R&D project, in HDT we will perform the first trial with patients to study the usual consumption of a mycotherapy formula in cases of metabolic syndrome (SM). This syndrome, according to the International Diabetes Federation, describes the conjunction of at least three of these five risk factors: abdominal obesity, arterial hypertension, high levels of triglycerides and glucose and reduced levels of HDL cholesterol. Currently, official data on metabolic syndrome suggest that 25 % of the world's population suffers from it.